Endocrine Society GUIDELINES Bundle (free trial)


Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140187

Contents of this Issue


Page 19 of 19

Abbreviations BZA, bazedoxifene; CEE, conjugated equine estrogens; CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; DVT, deep vein thrombosis; E, estrogen; E2, 17-B estradiol; EPT, estrogen plus progestogen therapy; ES, Endocrine Society; ET, estrogen therapy; GSM, genitourinary syndrome of menopause; HR, hazard ratio; IBIS, International Breast Intervention Study; IUD, intrauterine device; LNorg, levonorgestrel; MetS, metabolic syndrome; MHT, menopausal hormone therapy; MI, myocardial infarction; MPA, medroxyprogesterone acetate; NCI, National Cancer Institute; Neta, norethindrone acetate or norethisterone acetate; OTC, over the counter; PE, pulmonary embolism; POI, primary ovarian insufficiency; qd, once daily; QOL, quality of life; RCT, randomized controlled trial; SERM, selective estrogen receptor modulator; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin-norepinephrine reuptake inhibitor; T4, thyroxine; TG, triglycerides; TIA, transient ischemic attack; TSH, thyroid stimulating hormone; VMS, vasomotor symptoms; VTE, venous thromboembolism; VVA, vulvovaginal atrophy; WHI, Women's Health Initiative Source Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. Grading System Strength of Recommendation 1 = strong 2 = less strong US = Ungraded best practice statement Quality of Evidence ⊕⊕⊕⊕ = high ⊕⊕⊕ = moderate ⊕⊕ = low ⊕ = very low 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies, at GuidelineCentral.com Copyright © 2016 All rights reserved ESMEN16013 Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It focuses on the needs of primary care practice, but also is applicable to providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.

Articles in this issue

Links on this page

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Menopause